𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid in primary biliary cirrhosis: Reply

✍ Scribed by Ulrich Beuers; Michael Trauner

Book ID
116652023
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
51
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ursodeoxycholic acid therapy in primary
Ursodeoxycholic acid therapy in primary biliary cirrhosis
✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic

Biliary bile acids in primary biliary ci
Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Santiago Munoz; Guada πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed